In late December of 2013, the US Preventive Services Task Force (USPSTF) provided an update to its 2005 recommendations, reaffirming the genetic risk assessment and breast cancer susceptibility gene ...
About 1 in 8 women will be diagnosed with breast cancer in her lifetime. But the proportion who develop the common cancer as a result of a genetic mutation — namely to the BRCA1 or BRCA2 genes — is ...
An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...
Breast cancer awareness month marks a great time to brush up on your knowledge regarding the importance of BRCA gene testing. BRCA gene testing scans the body for mutations in both the BRCA1 and BRCA2 ...
ROANOKE, Va. – It’s estimated that more than 42,000 people will die from breast cancer this year, according to the American Cancer Society. To help you understand if you’re at a greater risk of ...
Not only do home genetic test kits, like 23andMe, provide information about your ancestry, but they can also give you some insights into your inherited health risks, particularly mutations on the BRCA ...
Although cancer is not usually inherited, certain types, including breast and ovarian, can be triggered by inherited gene faults, meaning they can run in families. Now that we can test for these ...
It might feel like your world stops after receiving a diagnosis of breast or ovarian cancer. Even in that mental and emotional fog, there are several next steps to consider. Coming up with a treatment ...
Harmful variants in the BRCA1 gene greatly increase a person's lifetime risk of developing breast, ovarian and pancreatic cancers, but most people are unaware they are carriers. In a new study in the ...
In the advent of targeted therapy in ovarian cancer, BRCA gene & “BRCA-ness” genes play a pivotal role in identifying the right patient for the right treatment. In this talk, we will details on the ...
Despite unequivocal recommendations for universal germline BRCA testing in women with ovarian cancer, an analysis of a large commercial insurance database between 2008 and 2018 found that only about ...
IT affects one in eight men, and so it seems logical to have a prostate cancer screening programme. And yet, in a pivotal decision today, deemed “deeply disappointing” by charities, campaign groups ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback